3 completed, 1 unknown. 3 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 3 | Completed 3 |
Follow IMBiotechnologies Ltd.: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Evaluate the Safety and Effectiveness of Using Echogenic Embolic Agent for Embolization of Prostate Artery for Treatment of Men With BPH (PAE CEUS) Embolization of prostatic artery under ultrasound guidance - Benign Prostatic Hyperplasia | Unknown | University of Calgary | 15 | 2020-03-01 | 2020-02-17 | |
| OCL 500 Treatment of Women With Symptomatic Uterine Fibroids Occlusin 500 Microspheres - Uterine Fibroid, Myoma | Not applicable | Completed | IMBiotechnologies Ltd. | 12 | 2018-01-17 | 2019-09-12 |
| Safety and Efficacy of OCL 503 in Prostate Artery Embolization Prostate artery embolization. - Benign Prostatic Hyperplasia, Benign Prostatic Hypertrophy | Not applicable | Completed | IMBiotechnologies Ltd. | 10 | 2015-09-01 | 2018-08-08 |
| Safety and Effectiveness of OCL 503 in the Treatment of Women With Leiomyomata OCL 503 (uterine artery embolization) - Leiomyomata | Not applicable | Completed | IMBiotechnologies Ltd. | 3 | 2015-04-01 | 2018-12-05 |
Prostatic Hyperplasia (2) · Leiomyoma (1) · Myoma (1)
Uterine Artery Embolization (1)
Canada (2) · United States (1)
Richard Owen, MD (2) · Gary Siskin, MD (1)